Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Illumina Laboratory Services, |
RCV000369382 | SCV000382706 | benign | Porencephaly 2 | 2018-01-12 | criteria provided, single submitter | clinical testing | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. |
Labcorp Genetics |
RCV001795935 | SCV003020570 | benign | not provided | 2023-11-06 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002520861 | SCV003548172 | uncertain significance | Inborn genetic diseases | 2021-04-20 | criteria provided, single submitter | clinical testing | The c.4985G>A (p.R1662H) alteration is located in exon 48 (coding exon 47) of the COL4A2 gene. This alteration results from a G to A substitution at nucleotide position 4985, causing the arginine (R) at amino acid position 1662 to be replaced by a histidine (H). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |
Laboratory of Diagnostic Genome Analysis, |
RCV001795935 | SCV002036611 | uncertain significance | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV001795935 | SCV002037642 | uncertain significance | not provided | no assertion criteria provided | clinical testing |